Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Income from Non-Controlling Interests came in at -$2341.5 in Q1 2026, up 25.8% year-on-year from -$1861.3 in Q1 2025, and up 32.95% on a QoQ basis from -$3492.1 in Q4 2025.

Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has 7 years of Income from Non-Controlling Interests data on file, last reported at -$2341.5 in Q1 2026.

  • On a quarterly basis, Income from Non-Controlling Interests rose 25.8% year-over-year to -$2341.5 in Q1 2026; TTM through Mar 2026 was -$8171.7, a 41.66% increase from a year earlier, with the FY2025 full-year figure at -$9312.3, up 27.38% from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at -$2341.5, up from -$3492.1 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for STVN reached as high as $99236.3 in Q2 2022 and fell as low as -$39789.6 in Q4 2022.
  • Historically, Income from Non-Controlling Interests has averaged $13603.0 across 5 years, with a median of -$2163.2 in 2024.
  • Across the five-year window, Income from Non-Controlling Interests surged 423.99% in 2022 and slumped 404.42% in 2024, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at -$39789.6 in 2022, then surged by 105.41% to $2151.9 in 2023, then plunged by 248.98% to -$3205.8 in 2024, then slipped by 8.93% to -$3492.1 in 2025, then soared by 32.95% to -$2341.5 in 2026.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$2341.5 in Q1 2026, -$3492.1 in Q4 2025, and -$2338.1 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 126.12 Bn 120.90 Bn 1.96 Bn -18.70 Mn
2 Becton Dickinson 44.89 Bn 44.07 Bn 2.15 Bn -
3 Alcon 33.06 Bn 31.40 Bn 1.53 Bn -
4 Medline 32.81 Bn 30.58 Bn 1.84 Bn 110.00 Mn
5 Resmed 29.44 Bn 27.78 Bn 890.98 Mn -
6 West Pharmaceutical Services 23.12 Bn 22.68 Bn 329.20 Mn -
7 Solventum 14.06 Bn 13.50 Bn 1.10 Bn -
8 Cooper Companies 13.87 Bn 13.73 Bn 735.40 Mn -
9 Align Technology 12.07 Bn 11.01 Bn 736.59 Mn -
10 Stevanato Group S.p.A 5.42 Bn 5.28 Bn 88.01 Mn -2,341.49

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,341.49
Dec 31, 2025 -3,492.13
Sep 30, 2025 -2,338.11
Mar 31, 2025 -3,155.65
Dec 31, 2024 -3,205.79
Sep 30, 2024 -5,491.10
Jun 30, 2024 -2,153.78
Mar 31, 2024 -2,172.72
Dec 31, 2023 2,151.88
Sep 30, 2023 -1,088.59
Jun 30, 2023 43,556.98
Mar 31, 2023 19,320.15
Dec 31, 2022 -39,789.65
Sep 30, 2022 72,595.75
Jun 30, 2022 99,236.27
Mar 31, 2022 46,015.85
Dec 31, 2021 -82,365.91
Sep 30, 2021 -22,406.46
Jun 30, 2021 30,106.79
Mar 31, 2021 16,887.31